Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
The U.S. Senate has launched an investigation into the high price of Novo Nordisk‘s popular weight loss and diabetes drugs…
Two fresh ways to play the weight loss and megacap tech hype
A major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks. In…
LVMH shares jump over 12% as earnings point to luxury sector resilience
LVMH shares jumped more than 12% on Friday morning, after the world’s largest luxury group posted higher-than-expected sales for 2023…
‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News…
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
Check out the companies making big moves midday. Novo Nordisk — The Danish drugmaker stock added 6.27% after saying late…
